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Non-alcoholic fatty liver disease (NAFLD) is a condition defined by significant lipid accumulation (5–10%) in hepatic tissue in the absence of significant chronic 
alcohol consumption [1]. Most of the patients with NAFLD have 
increased liver fat content alone (simple steatosis), but others 
may develop increasing hepatic inflammation known as non-
alcoholic steatohepatitis, and up to 20% of the patients reveal 
progressive hepatic fibrosis and may eventually develop cirrhosis 
or liver failure [1,2]. Estimates from recent epidemiological 
studies indicate a prevalence rate of 10–30% in the Western adult 
populations [3-5] as well as in Asian populations [6-9].
NAFLD is the most common cause of liver disease in children 
and its primary cause is obesity. In children, NAFLD causes a 
particular pattern of liver damage that is the most severe in 
children who are non-white, boys, or are especially obese [10]. 
In addition, children with NAFLD may be at increased risk for 
cardiovascular disease [11]. A long-term retrospective study 
conducted by researchers at Mayo Clinic showed that children 
with NAFLD are more than 13 times as likely to die over a 
20-year period or require a liver transplant as kids in the general 
population [12].
The great interest in diagnosing obesity and intervening as 
early as possible in children and adolescents derives from the 
fact that, in this age group, different from adults, the evolution 
of NAFLD and metabolic syndrome can be prevented or even 
slowed down since the repair processes in young people may be 
more active than in adult [13]. We planned this study to determine 
the prevalence of NAFLD in overweight and obese children and 
adolescents and to study its correlation of NAFLD with various 
anthropometric measures and laboratory parameters.
MATERIALS AND METHODS
This cross-sectional observational study was conducted 
on 30 children, aged 6–18 years attending the outpatient 
endocrinology clinic at the Department of Pediatrics of a 
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teaching institution of central India for complaint of increasing 
weight. Prior approval from the Institutional Ethics Committee 
was obtained, and informed consent was taken from the study 
subject and their parents before recruitment. Children, aged 
6–18 years with body mass index (BMI) ≥85th percentile for 
particular age and sex, were included in the study. Children 
with BMI <85th percentile for the particular age and sex, 
children <6 years and >18 years of age, and children with a 
history of use of drugs known to cause fatty changes in the liver 
were excluded from the study.
Demographic profile was recorded for all the patients. As per 
the standard methods of measurement, their weight, height, BMI, 
waist circumference (WC), hip circumference, waist/hip ratio, and 
neck circumference (NC) were measured. BMI was interpreted 
as per CDC guidelines (for age <18 years) [14]. WC percentiles 
were generated according to Kurian’s chart [15]. Cutoff value for 
NC was adopted from the USA study [16]. Waist/hip ratio was 
interpreted as per Huxley criteria [17]. The study subjects were 
divided into two groups: Group A included overweight (BMI 
between 85th and 95th percentiles) and Group B included obese 
(BMI ≥ 95th percentile) children.
Various biochemical tests were performed from all the study 
subjects including aspartate transaminase (AST) and alanine 
aminotransferase (ALT) levels. Normal value was taken as 
≤37 IU/L for AST and ≤40 U/L for ALT. Fasting blood samples 
were taken after a minimum fasting of 8 h for estimating plasma 
glucose and fasting serum insulin levels. Homeostatic model 
assessment of insulin resistance (HOMA-IR) was estimated using 
formula [18]: HOMA-IR = fasting blood sugar (mg/dL) × fasting 
insulin (mmol/L)/405. Two cutoffs were taken to define insulin 
resistance: (1) HOMA-IR 1 >75th centile and (2) HOMA-IR 2 
>90th centile.
Finally, ultrasonography (USG) abdomen of the study 
subjects was carried out in the Department of Radiodiagnosis to 
determine the liver size and echotexture (fatty changes). Liver 
echotexture was graded according to Mottin’s criteria [19]. 
(1) Grade I (mild) - a slight diffuse increase in fine echoes 
in the hepatic parenchyma with normal visualization of 
the diaphragm and intrahepatic vessel borders. (2) Grade II 
(moderate) - a moderate diffuse increase in fine echoes with 
slightly impaired visualization of the intrahepatic vessels 
and diaphragm. (3) Grade III (marked) - marked increase in 
fine echoes with poor or no visualization of the diaphragm, 
intrahepatic vessel borders, and posterior portion of the right 
lobe of the liver.
All relevant data collected from the patient were entered in 
a pre-designed pro forma. Statistical analysis was done using 
computer software (SPSS version 20). The qualitative data were 
expressed in proportion and percentages and the quantitative 
data were expressed as mean and standard deviations. The 
difference in proportion was analyzed using Chi-square test 
and the difference in means was analyzed using student t-test 
(unpaired). Significance level for tests was determined as 95%. 
Test is considered significant if p<0.05.
RESULTS
A total of 30 subjects were included in the study over a period 
of 1 year. 17 (57%) males and 13 (43%) females were the study 
subjects. 20% (6/30) of the study population were in the age group 
of <10 years and 80% (24/30) were ≥10 years of age. In this cohort, 
overweight males were 3, obese males were 14, overweight females 
were 6, and obese females were 7. Clinical, anthropometric, and 
biochemical characteristics are depicted in Table 1.
Out of 30 subjects, seven showed abnormal echotexture 
on sonography. Out of 13 females, 3 (23%) had abnormal 
echotexture, and out of 17 males, 5 (23.5%) had abnormal liver 
echotexture. Prevalence of NAFLD in obese children was 28.5% 
(6/21) and 11.1% (1/9) in overweight children. Four subjects had 
Grade I NAFLD and three had Grade II NAFLD. Rising trend 
of BMI percentile values with increasing echotexture of liver on 
USG are shown in Table 2. Out of three overweight children with 
normal NC, all had normal USG, while among six overweight 
children with NC more than normal, 5 (83.3%) had normal USG, 
and 1 (16.7%) had Grade I liver echotexture findings.
Out of three males with waist/hip ratio <0.9, all 3 (100%) 
had normal USG. 14 males had waist/hip ratio >0.9, and out of 
them, 10 (71.4%) had normal USG, 1 (7.1%) had Grade I, and 
3 (21.4%) had Grade II changes on USG (p>0.99). All the three 
females with waist/hip ratio <0.8 had normal USG. 7 out of 
10 (70%) females with waist/hip ratio >0.8 had normal USG and 
3 (30%) had Grade I liver changes.
Relationship of USG findings with liver function tests is shown 
in Table 3. Out of 23 subjects with normal AST levels, 21 (91%) 
had normal USG, while only 2 (9%) had liver changes. Out of 
seven subjects with AST levels >37 U/l, 5 (72%) had altered 
liver echotexture on USG (p=0.00006). Out of 22 subjects with 
normal ALT levels, 19 (86%) had normal USG, while 3 (14%) 
had Grade I changes. Out of eight subjects with ALT >40 U/l, 
4 (50%) had normal USG, 2 (25%) had Grade I, and 2 (25%) had 
Grade II changes (p=0.037).
Table 1: Clinical, anthropometric, and biochemical characteristics 
of the subjects
Parameters Mean±SD (range) n=30
Age (years) 12.7±3.3 (7–19)
BMI (kg/m2) 27.7±4.2 (20–35.9)
WC (cm) 92.3±12.7 (67–116)
Waist/hip 0.93±0.09 (0.77–1.17)
NC (cm) 34.1±2.8 (28–40)
Fasting sugar (mg/dL) 87.1±7.6 (73.1–107)
Fasting insulin (mcu/mL) 17.4±13.5 (1.6–61)
AST (U/L) 32.7±9.9 (19–64)
ALT (U/L) 34.2±19.1 (14–100)
HOMA-IR 3.7±3.07 (0.4–14.5)
Liver size in USG (cm) 12.4±1.8 (8.5–15.5)
NC: Neck circumference, WC: Waist circumference, BMI: Body 
mass index, ALT: Alanine aminotransferase, AST: Aspartate 
transaminase, HOMA-IR: Homeostatic model assessment of insulin 
resistance, USG: Ultrasonography, SD: Standard deviation
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Subjects’ HOMA-IR was correlated with liver echotexture as 
shown in Table 4. 11 (36.6%) subjects had normal HOMA-IR, 
while 19(63.4%) had high HOMA-IR. Higher HOMA-IR was 
associated with abnormal liver echotexture, although it was 
statistically not significant (p>0.05).
DISCUSSION
In the present study, the prevalence of NAFLD among obese 
children was found to be 28.5%, while among overweight 
children, it was 11.1%. Overall prevalence of NAFLD in those 
with BMI >85th percentile for the corresponding age and sex was 
found to be 23.3%. In earlier studies, the prevalence of NAFLD 
has been reported to range from as low as 20% to as high as 77% 
in other studies as conducted by Chan et al. [20-25]. In our study, 
the prevalence of NAFLD was almost equal in both the sexes 
(23.5% in males and 23.1% in females), which is in accordance 
with other studies [21-25].
Our study has shown positive correlation of BMI percentile 
values with normal, Grade I and Grade II liver echotexture finding 
on USG, although this difference was not significant (p=0.127). 
Tominaga et al. showed a strong correlation of NAFLD with 
BMI in their study [26]. Out of three overweight children with 
normal NC, all had normal USG, while among six overweight 
children with NC more than normal, 5 (83.3%) had normal USG, 
and 1 (16.7%) had Grade I changes. No literature could be found 
correlating the NC with NAFLD. Further studies are required to 
establish the relationship between the two.
In our study, we found a significant association between 
elevated AST and ALT levels with increased echogenicity on 
USG. Thus, it can be concluded that steatosis has a significant 
chance of being associated with steatohepatitis. Earlier studies 
have shown that AST and ALT values are either more than normal 
or in the high normal range in patients with NAFLD [27].
Pathogenesis of the NAFLD is not completely understood. 
The first step appears to involve deposition of excess fat in 
the liver; this is followed in some patients by increased fatty 
acid oxidation, oxidative stress, and cytokine production, 
resulting in progression to steatohepatitis and fibrosis. 
Various pathogenetic mechanisms that pay a role include 
cytokines (tumor necrosis factor-α, adiponectin, resistin, 
leptin, interleukins, and transforming growth factor ß) that 
lead to insulin resistance, and serum and liver iron overload 
and oxidative stress that lead to necroinflammation and 
fibrosis [28]. Thus, it becomes important in obese children to 
assess the liver function tests and extent of changes in liver 
echotexture for timely intervention.
In the present study, relationship between NAFLD and insulin 
resistance was not found to be statistically significant. However, 
earlier studies have shown that chances of NAFLD increase 
significantly with increasing insulin resistance [13,29]. Small 
sample size was the main limitation for establishing this fact. 
However, this study could be used as a base to perform further 
studies on a larger scale.
Table 4: Correlation of HOMA-IR with liver echotexture
HOMA-IR Normal NAFLD I NAFLD II Total Chi-square p value
0–2 11 0 0 11 5.2 0.02
2.1–4 7 2 1 10 0.37 0.54
4.1–6 2 1 0 3 0.18 0.66
6.1–8 1 1 1 3 3.49 0.06
8.1–10 0 0 1 1 3.3 0.06
>10 2 0 0 2 0.65 0.41
Total 23 4 3 30
HOMA-IR: Homeostatic model assessment of insulin resistance, NAFLD: Non-alcoholic fatty liver disease
Table 2: Relationship between liver echotexture findings on USG and BMI
BMI Normal NAFLD Grade I NAFLD Grade II p value
Number of cases 23 4 3 0.127
BMI percentile (mean±SD) 95.66±3.6 96.42±2.55 98.66±0.6
USG: Ultrasonography, BMI: Body mass index, NAFLD: Non-alcoholic fatty liver disease
Table 3: Relationship between liver echotexture finding on USG with AST and ALT
Laboratory tests Normal USG Grade I Grade II Total p value
Normal AST levels (<37 U/l) 21 2 0 23 0.0006
AST >37 U/l 2 3 2 7
Normal ALT levels (<40U/l) 19 3 0 22 0.037
ALT >40 U/l 4 2 2 8
Total 23 5 2 30
ALT: Alanine aminotransferase, AST: Aspartate transaminase, USG: Ultrasonography
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CONCLUSION
Obesity and overweight are associated with increased risk of 
NAFLD. Abnormal liver function test in overweight and obese 
children should raise the suspicion of NAFLD. All these children 
with high AST and ALT need sonography screening and regular 
follow-up and monitoring.
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